Anti-SRP myopathy: Different entity from myositis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Anti-signal recognition particle (SRP) antibody, detected in 5-8% of patients with clinical diagnosis of myositis, had been associated with severe and refractory myositis. However, it has been accepted that anti-SRP myopathy should be separated from myositis based on histological features of necrotizing myopathy. We reviewed clinical features of 27 patients with anti-SRP myopathy, and analyzed disease progression and neurological outcome. Anti-SRP antibodies in serum were detected by RNA immunoprecipitation assay using extracts of K562 cells. Of the 27 patients, 5 (18.5%) showed chronic progressive muscle weakness as well as atrophy of limbs and trunk muscles from a younger age with more severe neurological outcomes compared to the other 22 patients with the subacute form. A subset of patients with anti-SRP myopathy can show a chronic progressive form associated with severe clinical deficits.

Original languageEnglish
Pages (from-to)1148-1150
Number of pages3
JournalClinical Neurology
Volume52
Issue number11
DOIs
Publication statusPublished - 2012

Fingerprint

Signal Recognition Particle
Myositis
Muscular Diseases
Muscular Atrophy
K562 Cells
Antibodies
Muscle Weakness
Immunoprecipitation
Disease Progression
Extremities
RNA
Muscles
Serum

Keywords

  • Autoantibodies
  • Necrotizing myopathy
  • RNA immunoprecipitation
  • Signal recognition particle (SRP)

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Anti-SRP myopathy : Different entity from myositis. / Suzuki, Shigeaki.

In: Clinical Neurology, Vol. 52, No. 11, 2012, p. 1148-1150.

Research output: Contribution to journalArticle

@article{f0c9b418c9f44c8fb461f282913f657e,
title = "Anti-SRP myopathy: Different entity from myositis",
abstract = "Anti-signal recognition particle (SRP) antibody, detected in 5-8{\%} of patients with clinical diagnosis of myositis, had been associated with severe and refractory myositis. However, it has been accepted that anti-SRP myopathy should be separated from myositis based on histological features of necrotizing myopathy. We reviewed clinical features of 27 patients with anti-SRP myopathy, and analyzed disease progression and neurological outcome. Anti-SRP antibodies in serum were detected by RNA immunoprecipitation assay using extracts of K562 cells. Of the 27 patients, 5 (18.5{\%}) showed chronic progressive muscle weakness as well as atrophy of limbs and trunk muscles from a younger age with more severe neurological outcomes compared to the other 22 patients with the subacute form. A subset of patients with anti-SRP myopathy can show a chronic progressive form associated with severe clinical deficits.",
keywords = "Autoantibodies, Necrotizing myopathy, RNA immunoprecipitation, Signal recognition particle (SRP)",
author = "Shigeaki Suzuki",
year = "2012",
doi = "10.5692/clinicalneurol.52.1148",
language = "English",
volume = "52",
pages = "1148--1150",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - Anti-SRP myopathy

T2 - Different entity from myositis

AU - Suzuki, Shigeaki

PY - 2012

Y1 - 2012

N2 - Anti-signal recognition particle (SRP) antibody, detected in 5-8% of patients with clinical diagnosis of myositis, had been associated with severe and refractory myositis. However, it has been accepted that anti-SRP myopathy should be separated from myositis based on histological features of necrotizing myopathy. We reviewed clinical features of 27 patients with anti-SRP myopathy, and analyzed disease progression and neurological outcome. Anti-SRP antibodies in serum were detected by RNA immunoprecipitation assay using extracts of K562 cells. Of the 27 patients, 5 (18.5%) showed chronic progressive muscle weakness as well as atrophy of limbs and trunk muscles from a younger age with more severe neurological outcomes compared to the other 22 patients with the subacute form. A subset of patients with anti-SRP myopathy can show a chronic progressive form associated with severe clinical deficits.

AB - Anti-signal recognition particle (SRP) antibody, detected in 5-8% of patients with clinical diagnosis of myositis, had been associated with severe and refractory myositis. However, it has been accepted that anti-SRP myopathy should be separated from myositis based on histological features of necrotizing myopathy. We reviewed clinical features of 27 patients with anti-SRP myopathy, and analyzed disease progression and neurological outcome. Anti-SRP antibodies in serum were detected by RNA immunoprecipitation assay using extracts of K562 cells. Of the 27 patients, 5 (18.5%) showed chronic progressive muscle weakness as well as atrophy of limbs and trunk muscles from a younger age with more severe neurological outcomes compared to the other 22 patients with the subacute form. A subset of patients with anti-SRP myopathy can show a chronic progressive form associated with severe clinical deficits.

KW - Autoantibodies

KW - Necrotizing myopathy

KW - RNA immunoprecipitation

KW - Signal recognition particle (SRP)

UR - http://www.scopus.com/inward/record.url?scp=84880524428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880524428&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.52.1148

DO - 10.5692/clinicalneurol.52.1148

M3 - Article

C2 - 23196545

AN - SCOPUS:84880524428

VL - 52

SP - 1148

EP - 1150

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -